Categories
Lupin Limited — Updates, 18-05-2026: Press Release
18-05-2026 · 09:08 pm
Lupin secured US FDA tentative approval for its Revefenacin Inhalation Solution. The reference product had estimated annual US sales of USD 26.07 Cr, signaling a potential new revenue stream for the company.
No comments yet. Be the first to comment!